Protalix BioTherapeutics, Inc. Common Stock
$2.72
▼ 0.03
(-1.09%)
Volume: 386,024
· 2026-09-25
Loading…
RSI (14)
🧭 Style Verdicts
🚀
Momentum
71
- 21d momentum +9.7%
- MA aligned bullish
- RSI 56
🎯
Pullback
50
- +1.5% vs 20MA
💎
Value
50
- No fundamental data
Scores (0–100) derived from live technical & fundamental metrics. Not investment advice.
📐 Technicals
RSI(14)56.4
MACD-0.003
MA trendBullish
ATR3.47%
21d mom.+9.7%
63d mom.+18.3%
vs 20MA+1.5%
RVOL(20)0.52×
52w low · 2
52w high · 3
-14.7% from 52-week high
20d support 3
· resistance 3
Computed live from daily OHLCV · as of 2026-09-25
🏦 Fundamentals
Market cap$222M
PER11.70
PBR3.10
PSR2.75
EPS$0.24
ROE26.5%
ROA17.2%
Dividend yield0.00%
Debt/Equity0.00
EV/EBITDA7.81
| week | 1M | 3M | 6M | 1Y | YTD |
|---|---|---|---|---|---|
| +1.12% | +9.68% | +18.26% | +28.91% | +32.04% | +56.32% |
Valuation and profitability in USD, latest reported 2026-09-24. Period returns are price-based.
⚖️ AI Bull vs Bear
14d momentum +1.87%, daily vol 2.17%. Protalix BioTherapeutics, Inc. Common Stock sits in a bearish regime.
Derived from 14-day momentum and daily volatility on real OHLCV.
🗞 Related News
No recent news.